Cytek Biosciences, Inc. (CTKB)

6,20 -0,17 (-2,67%) Alla chiusura: 04:00PM EDT

Cytek Biosciences, Inc.

47215 Lakeview Boulevard
Fremont, CA 94538
United States
877 922 9835
https://cytekbio.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 676

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Wenbin Jiang Ph.D.	President, CEO & Chairman of the Board	939,24k	N/D	1964
Dr. Ming Yan Ph.D.	CTO & Director	570,12k	N/D	1963
Ms. Valerie T. Barnett J.D.	Chief Legal Officer & Corporate Secretary	612,39k	N/D	1975
Dr. Allen B. Poirson Ph.D.	Senior Vice President of Business & Corporate Development	576,28k	N/D	1960
Mr. Patrik Sebastian Jeanmonod	Head of Corporate Development Analytics	536,09k	N/D	1967
Mr. William D. McCombe	Chief Financial Officer	N/D	N/D	1958
Mr. Chris Williams	Chief Operating Officer	N/D	N/D	1969
Dr. Philippe Busque Ph.D.	Senior Vice President of Global Sales & Services	N/D	N/D	1971

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Governance aziendale

L'ISS Governance QualityScore di Cytek Biosciences, Inc. al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 7; diritti degli azionisti: 8; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.